Christopher D Alafi Insider Trading $ITCI Intra-Cellular Therapies, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Christopher D Alafi.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Christopher D Alafi. Christopher D Alafi is 10% Owner in Stereotaxis, Inc. ($STXS) and Director in Stereotaxis, Inc. ($STXS) and Director in Intra-Cellular Therapies, Inc. ($ITCI).
Christopher D Alafi in Intra-Cellular Therapies, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Christopher D Alafi: Director
Holdings: 133,843 shares
Current Value: $1,946,077
Latest Transaction: May 28 2021
$ITCI Market Capitalization: $607.92M
$ITCI Previous Close: $14.54
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Christopher D Alafi in Intra-Cellular Therapies, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 28 2021 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Sell | S | 40.12 | 38,843 | 1,558,381 | 95,000 | 133.8 K to 95 K (-29.02 %) |
| May 28 2021 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Sell | S | 40.01 | 8,482 | 339,365 | 133,843 | 142.3 K to 133.8 K (-5.96 %) |
| Apr 02 2021 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 33.93 | 464 | 15,744 | 346,795 | 346.3 K to 346.8 K (+0.13 %) |
| Sep 14 2020 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 29.60 | 49,500 | 1,465,200 | 4,743,770 | 4.7 M to 4.7 M (+1.05 %) |
| Sep 11 2020 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 28.08 | 21,000 | 589,680 | 4,694,270 | 4.7 M to 4.7 M (+0.45 %) |
| Jul 02 2020 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 25.67 | 613 | 15,736 | 345,223 | 344.6 K to 345.2 K (+0.18 %) |
| May 28 2020 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Option Exercise | A | 22.02 | 20,000 | 440,400 | 20,000 | |
| Apr 02 2020 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 15.37 | 1,024 | 15,739 | 344,610 | 343.6 K to 344.6 K (+0.30 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 34.31 | 422 | 14,479 | 343,586 | 343.2 K to 343.6 K (+0.12 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 34.31 | 422 | 14,479 | 343,586 | 343.2 K to 343.6 K (+0.12 %) |
| Oct 02 2019 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 7.47 | 1,941 | 14,499 | 343,164 | 341.2 K to 343.2 K (+0.57 %) |
| Sep 11 2019 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 11.00 | 6,240 | 68,640 | 4,673,270 | 4.7 M to 4.7 M (+0.13 %) |
| Sep 11 2019 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 10.58 | 320,095 | 3,386,605 | 4,667,030 | 4.3 M to 4.7 M (+7.36 %) |
| Sep 11 2019 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 9.59 | 155,116 | 1,487,562 | 4,346,935 | 4.2 M to 4.3 M (+3.70 %) |
| Sep 11 2019 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 8.98 | 3,549 | 31,870 | 4,191,819 | 4.2 M to 4.2 M (+0.08 %) |
| Sep 04 2019 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 8.52 | 125,000 | 1,065,213 | 4,188,270 | 4.1 M to 4.2 M (+3.08 %) |
| Jun 26 2019 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Option Exercise | A | 13.05 | 20,000 | 261,000 | 20,000 | |
| Jun 19 2019 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Gift | G | 0.00 | 400,000 | 0 | 340,106 | 740.1 K to 340.1 K (-54.05 %) |
| Jun 14 2019 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 12.00 | 58,705 | 704,460 | 170,000 | 111.3 K to 170 K (+52.75 %) |
| Jun 14 2019 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 11.70 | 95,069 | 1,112,307 | 111,295 | 16.2 K to 111.3 K (+585.91 %) |
| Jun 14 2019 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 10.91 | 16,226 | 177,026 | 16,226 | 0 to 16.2 K |
| May 15 2019 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 12.56 | 100,000 | 1,256,350 | 4,053,270 | 4 M to 4.1 M (+2.53 %) |
| Apr 02 2019 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 12.18 | 1,190 | 14,494 | 750,106 | 748.9 K to 750.1 K (+0.16 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 11.39 | 1,273 | 14,499 | 748,916 | 747.6 K to 748.9 K (+0.17 %) |
| Oct 02 2018 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 21.70 | 668 | 14,496 | 747,643 | 747 K to 747.6 K (+0.09 %) |
| Jun 20 2018 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Option Exercise | A | 20.39 | 20,000 | 407,800 | 20,000 | |
| Jun 20 2018 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Option Exercise | A | 20.39 | 20,000 | 407,800 | 20,000 | |
| Nov 27 2017 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 15.55 | 10,000 | 155,500 | 744,466 | 734.5 K to 744.5 K (+1.36 %) |
| Oct 03 2017 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 15.50 | 258,065 | 4,000,008 | 3,953,270 | 3.7 M to 4 M (+6.98 %) |
| Oct 03 2017 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 0.00 | 918 | 0 | 734,466 | 733.5 K to 734.5 K (+0.13 %) |
| Jul 05 2017 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 0.00 | 1,167 | 0 | 733,548 | 732.4 K to 733.5 K (+0.16 %) |
| Jun 29 2017 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Option Exercise | A | 12.45 | 20,000 | 249,000 | 20,000 | |
| Apr 04 2017 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 0.00 | 892 | 0 | 732,381 | 731.5 K to 732.4 K (+0.12 %) |
| Jan 03 2017 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 0.00 | 960 | 0 | 731,489 | 730.5 K to 731.5 K (+0.13 %) |
| Dec 07 2016 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 16.14 | 20,826 | 336,038 | 3,695,205 | 3.7 M to 3.7 M (+0.57 %) |
| Dec 07 2016 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 16.33 | 44,174 | 721,445 | 3,674,379 | 3.6 M to 3.7 M (+1.22 %) |
| Nov 17 2016 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 14.50 | 34,000 | 492,969 | 3,630,205 | 3.6 M to 3.6 M (+0.95 %) |
| Oct 04 2016 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 0.00 | 951 | 0 | 730,529 | 729.6 K to 730.5 K (+0.13 %) |
| Jul 05 2016 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 0.00 | 373 | 0 | 729,578 | 729.2 K to 729.6 K (+0.05 %) |
| Jun 15 2016 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Option Exercise | A | 38.35 | 20,000 | 767,000 | 20,000 | |
| Apr 04 2016 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 0.00 | 377 | 0 | 729,205 | 728.8 K to 729.2 K (+0.05 %) |
| Feb 29 2016 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 29.70 | 100,000 | 2,970,300 | 728,828 | 628.8 K to 728.8 K (+15.90 %) |
| Jan 05 2016 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 53.79 | 195 | 10,489 | 628,828 | 628.6 K to 628.8 K (+0.03 %) |
| Oct 02 2015 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 0.00 | 262 | 0 | 628,633 | 628.4 K to 628.6 K (+0.04 %) |
| Jul 02 2015 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 0.00 | 328 | 0 | 628,371 | 628 K to 628.4 K (+0.05 %) |
| Jun 22 2015 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Option Exercise | A | 26.58 | 20,000 | 531,600 | 20,000 | |
| Apr 02 2015 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 0.00 | 439 | 0 | 628,043 | 627.6 K to 628 K (+0.07 %) |
| Mar 12 2015 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 24.00 | 625,000 | 15,000,000 | 627,604 | 2.6 K to 627.6 K (+24,001.54 %) |
Page: 1